Optimizing treatment for chronic congestive heart failure in children

Critical Care Medicine

Volumn 29, Issue 10 SUPPL., 2001, Pages

  Shaddy, R E ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Children; Chronic heart failure; Digoxin; Diuretics; adrenergic receptor antagonists

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FOSINOPRIL; LISINOPRIL; METOPROLOL; PLACEBO; QUINAPRIL; SPIRONOLACTONE;

CHILD; CHRONIC DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; GYNECOMASTIA; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HUMAN; HYPERKALEMIA; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0034769562     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200110001-00006     Document Type: Review

References (36)

1. Neurohumoral activation and progression of heart failure: Hypothetical and clinical considerations
2. Consensus recommendations for the management of chronic heart failure
3. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
4. Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition: Mechanistic evidence to support RALES
5. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors
6. The effect of digoxin on mortality and morbidity in patients with heart failure
7. Effects of digoxin in infants with congested circulatory state due to a ventricular septal defect
8. Effect of digoxin on contractility and symptoms in infants with a large ventricular septal defect
9. Update on the interaction between aspirin and angiotensin-converting enzyme inhibitors
10. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure
11. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
12. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
13. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
14. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and morality in chronic heart failure
15. High- versus low-dose ACE inhibition in chronic heart failure: A double-blind, placebo-controlled study of imidapril
16. Short-term hemodynamic effects of captopril in infants with congestive heart failure
17. Captopril in infants for congestive heart failure secondary to a large ventricular left-to-right shunt
18. Orally administered enalapril for infants with congestive heart failure: A dose-finding study
19. Acute hemodynamic effects of converting enzyme inhibition in infants with congestive heart failure
20. Effects of captopril on the distribution of left ventricular output with ventricular septal defect
21. Acute hemodynamic effects of captopril in children with a congestive or restrictive cardiomyopathy
22. The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy
23. Enalapril does not enhance exercise capacity in patients after Fontan procedure
24. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
25. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
26. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
27. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
28. A randomized trial of β-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS)
29. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
30. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
31. Effect of carvedilol on survival in severe chronic heart failure
32. Mechanism of action of beta-blocking agents in heart failure
33. Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patients
34. β-blocker therapy in young children with congestive heart failure under consideration for heart transplantation
35. Betablocker treatment of dilated cardiomyopathy with congestive heart failure in children: A multi-institutional experience
36. Carvedilol as therapy in pediatric heart failure: An initial multicenter experience